Great Lakes Advisors, LLC Harmony Biosciences Holdings, Inc. Transaction History

Great Lakes Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$19.2 - $33.78 $2.69 Million - $4.72 Million	-139,867 Reduced 49.74%	141,301 $4.56 Million
Q3 2023 Nov 07, 2023	SELL	$31.89 - $39.03 $1.02 Million - $1.24 Million	-31,879 Reduced 10.18%	281,168 $9.21 Million
Q2 2023 Aug 10, 2023	SELL	$30.5 - $37.4 $2.84 Million - $3.48 Million	-93,133 Reduced 22.93%	313,047 $11 Million
Q1 2023 May 10, 2023	BUY	$30.8 - $53.92 $7.66 Million - $13.4 Million	248,651 Added 157.84%	406,180 $13.3 Million
Q4 2022 Feb 09, 2023	SELL	$45.4 - $60.91 $92,343 - $123,890	-2,034 Reduced 1.27%	157,529 $8.68 Million
Q3 2022 Nov 09, 2022	SELL	$42.06 - $55.45 $284,956 - $375,673	-6,775 Reduced 4.07%	159,563 $7.07 Million
Q2 2022 Aug 09, 2022	BUY	$33.54 - $52.15 $5.58 Million - $8.67 Million	166,338 New	166,338 $8.11 Million

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.05B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.